MHA Monday Report June 30, 2025

MHA Board of Trustees Holds Final Meeting of Program Year

The MHA Board of Trustees held its final meeting of the 2024-2025 program year on Mackinac Island June 25 in conjunction with the MHA Annual Membership Meeting. The meeting began with a welcome by the …


Opioid Legislation, IMLC and Compact Bills Advance in Senate, House

The Senate Health Policy Committee voted in support of legislation related to treating patients with opioid use disorder, while the House Health Policy advanced the Interstate Medical Licensure Compact (IMLC) bill during the week of …


Health & Hospital Association Elects 2025-2026 Officers and Board Members

Members of the MHA elected new officers and appointed board members during the association’s Annual Membership Meeting June 25. Officers of the 2025-2026 MHA Board of Trustees include Bill Manns, …


Hospital Executives Recognized for Outstanding Leadership

The MHA announced the winners of its 2025 Healthcare Leadership Award June 26 during its Annual Membership Meeting. Each year, the MHA recognizes outstanding individuals who have provided exceptional leadership to healthcare organizations and to …


Ludwig Community Benefit Award Honors Hospital Programs

The MHA announced the winners of its 2025 Ludwig Community Benefit Award during the association’s Annual Membership Meeting June 26. The honorees include programs supported by Corewell Health Lakeland Hospitals St. Joseph Hospital; Lake Huron …


MHA Meritorious Service Award Recognizes Bob Riney

The MHA announced the 2025 winner of its highest achievement award June 26 during the association’s Annual Membership Meeting. Receiving the award for his decades of healthcare leadership is Bob Riney, president and CEO, Henry …


Healthcare Advocates Honored with MHA Special Recognition Award

The MHA announced four winners of its Special Recognition Award during the Annual Membership Meeting June 26, recognizing them for extensive contributions to healthcare. Each of the winners has uniquely influenced healthcare in Michigan. The …


Keckley Report

The U.S. Anxiety Pandemic

“The U.S. bombing of Iran’s nuclear capability is unsettling: whether MAGA or not, hawk or dove, young or old, conservative or liberal, rich or poor—it matters. Stability at home and abroad is utopian to some but desired by all. Pandemics, mass violence, natural disasters and even election results contribute to instability and lend to insecurity. Operation Midnight Hammer might contribute to the nation’s anxiety—time will tell. …

Nothing could be more timely and necessary to the Commission’s work than addressing mass anxiety and mental health as a national priority. And nothing is more urgently needed in communities than mainstreaming anxiety and mental health into the systems of health that accept full risk for whole person health.”

Paul Keckley, June 23, 2025


New to KnowNews to Know

  • MHA offices will be closed and no formal meetings will be scheduled July 4 in honor of Independence Day.
  • Due to the holiday, Monday Report will not be published July 7 and will resume its normal schedule July 14. Member alerts and MHA newsroom articles will continue to be published during that time to provide relevant updates to the MHA membership, as necessary.

 

Senate Health Policy Holds Testimony on Opioid Legislation

The Senate Health Policy Committee held testimony on legislation related to treating patients with opioid use disorder during the week of June 16.

Collectively, Senate Bills (SB) 397405 make numerous changes to improve coverage and access for Michiganders to receive treatment for opioid use disorder. SBs 397, 400, 401, 402 and 403 specifically apply commercial insurer and Medicaid coverage modifications to reduce delays and remove additional barriers in prescribing opioid-related treatment and dosages.

SB 398 modifies opioid treatment program requirements under the Department of Licensing and Regulatory Affairs, while SBs 404405 would require nurses to carry naloxone in select schools. Lastly, SB 399 amends the Public Health Code to specify that the term “drug paraphernalia” does not include testing products.

The MHA-supported bills now await a final vote in the Senate Health Policy Committee before moving to the full Senate chamber. The MHA Behavioral Health Integration Council reviewed and recommended changes for SBs 397, 398, 399, 400 and 402.

Members with additional questions should contact the MHA Advocacy Team.